|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Pharma's Image Fix: Lessons from the Fieldalmost 8 years ago
The Innovation Distinction: Biopharma's Reputational Passalmost 8 years ago
Valeant’s Northern Facealmost 8 years ago
More New Drugs and Generics Reshape Pharma Marketsalmost 8 years ago
Leadership in All the Right Placesalmost 8 years ago
Industry Engine CheckNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
3
FDA Announces New Plausible Mechanism Pathway
4
DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026
5
